REPORT ID 6998

Asia-Pacific Hepatitis A Vaccine Market Report 2017

Publish Date
1-Nov-17
Pages
119
Format
Electronic (PDF)

In this report, the Asia-Pacific Hepatitis A Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Hepatitis A Vaccine for these regions, from 2012 to 2022 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Hepatitis A Vaccine market competition by top manufacturers/players, with Hepatitis A Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    GlaxoSmithKline
    Merck Sharp & Dohme Corp
    SANOFI PASTEUR S.A
    Norvatis
    Crucell Switzerland AG(Berna+Crucell)
    China Academy of Medical Sciences
    Changchun Institute of Biological Products
    Zhejiang Pukang
    ChangSheng
    Sinovac
    Shanghai Zerun Biotechnology

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Liver Inactivated Vaccine
    Live Attenuated Vaccine

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Hepatitis A Vaccine for each application, includin
    Hospitals
    Other Medical Institutions

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific Hepatitis A Vaccine Market Report 2017
1 Hepatitis A Vaccine Overview
    1.1 Product Overview and Scope of Hepatitis A Vaccine
    1.2 Classification of Hepatitis A Vaccine by Product Category
        1.2.1 Asia-Pacific Hepatitis A Vaccine Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific Hepatitis A Vaccine Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Liver Inactivated Vaccine
        1.2.4 Live Attenuated Vaccine
    1.3 Asia-Pacific Hepatitis A Vaccine Market by Application/End Users
        1.3.1 Asia-Pacific Hepatitis A Vaccine Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Hospitals
        1.3.3 Other Medical Institutions
    1.4 Asia-Pacific Hepatitis A Vaccine Market by Region
        1.4.1 Asia-Pacific Hepatitis A Vaccine Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Japan Status and Prospect (2012-2022)
        1.4.4 South Korea Status and Prospect (2012-2022)
        1.4.5 Taiwan Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
        1.4.7 Southeast Asia Status and Prospect (2012-2022)
        1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of Hepatitis A Vaccine (2012-2022)
        1.5.1 Asia-Pacific Hepatitis A Vaccine Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific Hepatitis A Vaccine Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Hepatitis A Vaccine Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Hepatitis A Vaccine Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Hepatitis A Vaccine Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific Hepatitis A Vaccine Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific Hepatitis A Vaccine (Volume and Value) by Type
        2.2.1 Asia-Pacific Hepatitis A Vaccine Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific Hepatitis A Vaccine Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific Hepatitis A Vaccine (Volume) by Application
    2.4 Asia-Pacific Hepatitis A Vaccine (Volume and Value) by Region
        2.4.1 Asia-Pacific Hepatitis A Vaccine Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific Hepatitis A Vaccine Revenue and Market Share by Region (2012-2017)

3 China Hepatitis A Vaccine (Volume, Value and Sales Price)
    3.1 China Hepatitis A Vaccine Sales and Value (2012-2017)
        3.1.1 China Hepatitis A Vaccine Sales Volume and Growth Rate (2012-2017)
        3.1.2 China Hepatitis A Vaccine Revenue and Growth Rate (2012-2017)
        3.1.3 China Hepatitis A Vaccine Sales Price Trend (2012-2017)
    3.2 China Hepatitis A Vaccine Sales Volume and Market Share by Type
    3.3 China Hepatitis A Vaccine Sales Volume and Market Share by Application

4 Japan Hepatitis A Vaccine (Volume, Value and Sales Price)
    4.1 Japan Hepatitis A Vaccine Sales and Value (2012-2017)
        4.1.1 Japan Hepatitis A Vaccine Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan Hepatitis A Vaccine Revenue and Growth Rate (2012-2017)
        4.1.3 Japan Hepatitis A Vaccine Sales Price Trend (2012-2017)
    4.2 Japan Hepatitis A Vaccine Sales Volume and Market Share by Type
    4.3 Japan Hepatitis A Vaccine Sales Volume and Market Share by Application

5 South Korea Hepatitis A Vaccine (Volume, Value and Sales Price)
    5.1 South Korea Hepatitis A Vaccine Sales and Value (2012-2017)
        5.1.1 South Korea Hepatitis A Vaccine Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea Hepatitis A Vaccine Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea Hepatitis A Vaccine Sales Price Trend (2012-2017)
    5.2 South Korea Hepatitis A Vaccine Sales Volume and Market Share by Type
    5.3 South Korea Hepatitis A Vaccine Sales Volume and Market Share by Application

6 Taiwan Hepatitis A Vaccine (Volume, Value and Sales Price)
    6.1 Taiwan Hepatitis A Vaccine Sales and Value (2012-2017)
        6.1.1 Taiwan Hepatitis A Vaccine Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan Hepatitis A Vaccine Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan Hepatitis A Vaccine Sales Price Trend (2012-2017)
    6.2 Taiwan Hepatitis A Vaccine Sales Volume and Market Share by Type
    6.3 Taiwan Hepatitis A Vaccine Sales Volume and Market Share by Application

7 India Hepatitis A Vaccine (Volume, Value and Sales Price)
    7.1 India Hepatitis A Vaccine Sales and Value (2012-2017)
        7.1.1 India Hepatitis A Vaccine Sales Volume and Growth Rate (2012-2017)
        7.1.2 India Hepatitis A Vaccine Revenue and Growth Rate (2012-2017)
        7.1.3 India Hepatitis A Vaccine Sales Price Trend (2012-2017)
    7.2 India Hepatitis A Vaccine Sales Volume and Market Share by Type
    7.3 India Hepatitis A Vaccine Sales Volume and Market Share by Application

8 Southeast Asia Hepatitis A Vaccine (Volume, Value and Sales Price)
    8.1 Southeast Asia Hepatitis A Vaccine Sales and Value (2012-2017)
        8.1.1 Southeast Asia Hepatitis A Vaccine Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia Hepatitis A Vaccine Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia Hepatitis A Vaccine Sales Price Trend (2012-2017)
    8.2 Southeast Asia Hepatitis A Vaccine Sales Volume and Market Share by Type
    8.3 Southeast Asia Hepatitis A Vaccine Sales Volume and Market Share by Application

9 Australia Hepatitis A Vaccine (Volume, Value and Sales Price)
    9.1 Australia Hepatitis A Vaccine Sales and Value (2012-2017)
        9.1.1 Australia Hepatitis A Vaccine Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia Hepatitis A Vaccine Revenue and Growth Rate (2012-2017)
        9.1.3 Australia Hepatitis A Vaccine Sales Price Trend (2012-2017)
    9.2 Australia Hepatitis A Vaccine Sales Volume and Market Share by Type
    9.3 Australia Hepatitis A Vaccine Sales Volume and Market Share by Application

10 Asia-Pacific Hepatitis A Vaccine Players/Suppliers Profiles and Sales Data
    10.1 GlaxoSmithKline
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Hepatitis A Vaccine Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 GlaxoSmithKline Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 Merck Sharp & Dohme Corp
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Hepatitis A Vaccine Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 Merck Sharp & Dohme Corp Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    10.3 SANOFI PASTEUR S.A
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Hepatitis A Vaccine Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 SANOFI PASTEUR S.A Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        10.3.4 Main Business/Business Overview
    10.4 Norvatis
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Hepatitis A Vaccine Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 Norvatis Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        10.4.4 Main Business/Business Overview
    10.5 Crucell Switzerland AG(Berna+Crucell)
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Hepatitis A Vaccine Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Crucell Switzerland AG(Berna+Crucell) Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        10.5.4 Main Business/Business Overview
    10.6 China Academy of Medical Sciences
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Hepatitis A Vaccine Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 China Academy of Medical Sciences Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        10.6.4 Main Business/Business Overview
    10.7 Changchun Institute of Biological Products
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Hepatitis A Vaccine Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Changchun Institute of Biological Products Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        10.7.4 Main Business/Business Overview
    10.8 Zhejiang Pukang
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Hepatitis A Vaccine Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        10.8.4 Main Business/Business Overview
    10.9 ChangSheng
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Hepatitis A Vaccine Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 ChangSheng Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        10.9.4 Main Business/Business Overview
    10.10 Sinovac
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 Hepatitis A Vaccine Product Category, Application and Specification
            10.10.2.1 Product A
            10.10.2.2 Product B
        10.10.3 Sinovac Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        10.10.4 Main Business/Business Overview
    10.11 Shanghai Zerun Biotechnology

11 Hepatitis A Vaccine Manufacturing Cost Analysis
    11.1 Hepatitis A Vaccine Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Hepatitis A Vaccine

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Hepatitis A Vaccine Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Hepatitis A Vaccine Major Manufacturers in 2016
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Hepatitis A Vaccine Market Forecast (2017-2022)
    15.1 Asia-Pacific Hepatitis A Vaccine Sales Volume, Revenue and Price Forecast (2017-2022)
        15.1.1 Asia-Pacific Hepatitis A Vaccine Sales Volume and Growth Rate Forecast (2017-2022)
        15.1.2 Asia-Pacific Hepatitis A Vaccine Revenue and Growth Rate Forecast (2017-2022)
        15.1.3 Asia-Pacific Hepatitis A Vaccine Price and Trend Forecast (2017-2022)
    15.2 Asia-Pacific Hepatitis A Vaccine Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.1 Asia-Pacific Hepatitis A Vaccine Sales Volume and Growth Rate Forecast by Region (2017-2022)
        15.2.2 Asia-Pacific Hepatitis A Vaccine Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.3 China Hepatitis A Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.4 Japan Hepatitis A Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.5 South Korea Hepatitis A Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.6 Taiwan Hepatitis A Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.7 India Hepatitis A Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.8 Southeast Asia Hepatitis A Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.9 Australia Hepatitis A Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
    15.3 Asia-Pacific Hepatitis A Vaccine Sales, Revenue and Price Forecast by Type (2017-2022)
        15.3.1 Asia-Pacific Hepatitis A Vaccine Sales Forecast by Type (2017-2022)
        15.3.2 Asia-Pacific Hepatitis A Vaccine Revenue Forecast by Type (2017-2022)
        15.3.3 Asia-Pacific Hepatitis A Vaccine Price Forecast by Type (2017-2022)
    15.4 Asia-Pacific Hepatitis A Vaccine Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
    17.1 Methodology/Research Approach
        17.1.1 Research Programs/Design
        17.1.2 Market Size Estimation
        17.1.3 Market Breakdown and Data Triangulation
    17.2 Data Source
        17.2.1 Secondary Sources
        17.2.2 Primary Sources
    17.3 Disclaimer